Skip to content

Author

V. Master

We have 6 of 1,001 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Prospectively Collected Functional vs. Self-reported Frailty Measures and Postoperative Outcomes after Radical Cystectomy in Older Adults with Bladder Cancer

Functional and self-reported frailty assessments provide different information characterizing individual vulnerability profiles; however, only the CARE-FI was statistically associated with increased LOS and postoperative complications following RC.

Jordan Sheldon, Sarah K. Holt, E. Brewer et al. · 0 citations
Oct 2026

Computerized Tomography-Derived Sarcopenia is Independently Associated With Acute Care Physical Therapy Utilization Among Patients With Renal Cell Carcinoma

Sarcopenia is prevalent among patients with renal cell carcinoma (RCC) and is an independent predictor of poor survival outcomes. This study evaluated the association between preoperative radiographic sarcopenia and receipt of postoperative physical therapy (PT) in patients with RCC. Adults who underwent n...

J. Lipinski, R. Lahiji, G. Fung et al. · 0 citations
Open access Sep 2026

Effect of demographic characteristics on the outcome of prostate cancer salvage radiotherapy: Analysis from a randomized controlled trial

This study investigated the impact of advanced molecular imaging, race, socioeconomic status, and metabolic dysregulation on the outcome of salvage radiotherapy (sRT) for prostate cancer recurrence in a clinical trial setting.

I. Lawal, A. Jani, Subir Goyal et al. · 0 citations
Sep 2026

Novel use of computed tomography-derived body composition to facilitate risk assessment in patients with bladder cancer.

BACKGROUND Comprehensive geriatric assessments (CGA) inform risk stratification in bladder cancer (BC) care but are time- and resource-intensive. PURPOSE To investigate whether body composition analysis (BCA) on computed tomography (CT) is associated with CGA. METHODS Patients with BC (any stage) were enrolled in a...

L. Mantz, Alex Zhu, N. Mercaldo et al. · 0 citations
Sep 2026

Risk-dependent Benefit of Adjuvant Pembrolizumab in High-risk Clear Cell Renal Cell Carcinoma: A Multi-institutional Study.

BACKGROUND Adjuvant pembrolizumab improves outcomes in high-risk clear cell renal cell carcinoma (ccRCC), but baseline recurrence risk varies substantially. OBJECTIVE To evaluate treatment selection, outcomes, toxicity, and risk-stratified benefit. DESIGN, SETTING, AND PARTICIPANTS A retrospective cohort of consecu...

D. D. Shapiro, D. Roadman, V. Master et al. · 1 citation
Open access Aug 2026

MSMICA: computational metabolite identification in untargeted metabolomics by integrating MS, retention time, and biological evidence

MSMICA applies multiple pieces of evidence to substantially improve metabolite identification coverage and accuracy for known metabolites and enables greater metabolite identifications, expanded metabolic pathway coverage, and data harmonization.

Jia-Da Zhan, J. Weinberg, William J. Crandall et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.